What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to inform investors and analysts that Elevance Health (then Anthem, Inc.) officers will be meeting with them during the week of January 14, 2002, to confirm the company's ability to meet previously announced earnings expectations.

What are the key risks mentioned in the filing that could impact Elevance Health's earnings?

The filing lists several key risks, including trends in healthcare costs and utilization, the ability to secure sufficient premium rate increases, competitor pricing, increased government regulation, significant competitor acquisitions or divestitures, the impact of new prescription drugs and technology, potential downgrades in financial strength ratings, litigation, provider contracting challenges, and general economic downturns.

What should investors consider regarding the forward-looking statements made by the company?

Investors are cautioned not to place undue reliance on these forward-looking statements. The company explicitly states that these statements are subject to risks and uncertainties and that actual results could differ materially. Elevance Health also indicates it has no obligation to update these statements for events or circumstances arising after the filing date.

ELV 8-K SEC Disclosure — Jan 14, 2002

Q: Does Elevance Health provide new earnings guidance in this filing?

No, this filing does not provide new earnings guidance. Instead, it serves to confirm the company's ability to meet the earnings expectations previously communicated in a press release and conference call on November 14, 2001.

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) is filing this Form 8-K to provide an update regarding upcoming meetings with securities analysts and investors scheduled for the week of January 14, 2002. The primary purpose of these meetings is to confirm the company's ability to meet the earnings expectations previously provided in a press release and conference call on November 14, 2001. This filing serves as a reminder of the forward-looking nature of these statements, highlighting potential risks and uncertainties that could impact actual results. Investors should be aware of factors such as healthcare cost trends, premium rate adjustments, competitive pricing, regulatory changes, significant market shifts, new drug and technology utilization, financial strength ratings, litigation, provider contracting, and general economic conditions. The company explicitly cautions against undue reliance on these forward-looking statements.

Key Highlights

1Company to meet with securities analysts and investors during the week of January 14, 2002.
2Confirmation of ability to meet earnings expectations provided on November 14, 2001.
3Reinforces the forward-looking nature of previous earnings guidance.
4Discloses a comprehensive list of risks and uncertainties that could affect future performance.
5Key risk factors include healthcare cost trends, premium rate increases, and government regulation.
6Also mentions risks related to competitor actions, new medical innovations, financial ratings, and economic downturns.
7Company reiterates that no obligation exists to update forward-looking statements for future events.

Elevance Health, Inc. 8-K Report (Jan 14, 2002)

Summary

Key Highlights

Frequently Asked Questions